FDAFDA · Food and drugs·Recall number D-0170-2021
Auryxia (ferric citrate) tablets, 210 mg, 200-count bottles, Rx only, Manufactured for and distributed by: KERYX BIOPHARMACEUTICALS, INC., One Marina Park Drive, 12th Floor, Boston, MA 02210, NDC 59922-631-01
Published December 30, 2020 · Recall initiated: December 9, 2020
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- AURYXIA
- Manufacturer
- Akebia Therapeutics dba Keryx Biopharmaceutials, Inc
- Distributor
- The product was distributed by two major distributors who further distributed the product nationwide and one specialty pharmacy.
- Lot
- Lot Number: 9062, exp. date Feb 2021
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.